Evidence map›Paper›PMID 40980827›Full record

ReviewACS infectious diseases2025

Synergistic Paradigms in Infection Control: A Review on Photodynamic Therapy as an Adjunctive Strategy to Antibiotics.

Jennifer Machado Soares, Thaila Quatrini Corrêa, Claudia Patricia Barrera Patiño, Isabella Salgado Gonçalves, Gabriel Grube Dos Santos, Gabriela Gomes Guimarães, Rebeca Vieira de Lima, Thalita Hellen Nunes Lima, Bruna Carolina Corrêa, Taina Cruz de Souza Cappellini and 5 more

Abstract readReview
In one paragraph

Review in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Advances in BODIPY Derivatives for Antibacterial Phototherapy.Angewandte Chemie (International ed. in English) · 2026
    Review
  4. Article
  5. Article
  6. Photodynamic Therapy in Dermatology.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Halogenated Vitamin BACS omega · 2026
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jennifer Machado SoaresSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0002-2978-7076
Thaila Quatrini CorrêaSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Claudia Patricia Barrera PatiñoSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Isabella Salgado GonçalvesSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Gabriel Grube Dos SantosSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Gabriela Gomes GuimarãesSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Rebeca Vieira de LimaSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Thalita Hellen Nunes LimaSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Bruna Carolina CorrêaSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Taina Cruz de Souza CappelliniSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Maria Vitória Silva PereiraSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Anna Luiza França de Oliveira ResendeSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Vladislav V YakovlevBiomedical Engineering, Texas A&M University, CPRIT Scholar in Cancer Research, College Station, Texas 77843, United States.ORCID 0000-0002-4557-1013
Kate Cristina BlancoSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.
Vanderlei Salvador BagnatoSão Carlos Institute of Physics, University of São Paulo, São Paulo 05508-900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing threat of antimicrobial resistance necessitates developing novel strategies to enhance the efficacy of existing antibiotics. This review explores the potential of antimicrobial photodynamic therapy (aPDT) as an adjunctive approach to antibiotic therapy. A systematic literature search was conducted in major scientific databases, focusing on studies published in the past decade investigating the synergistic effects of aPDT with antibiotics. Selected articles were analyzed based on their experimental approaches, bacterial targets, photodynamic parameters, and reported treatment outcomes. aPDT induces bacterial cell damage by generating reactive oxygen species (ROS), enhancing antibiotic susceptibility, and reducing required dosages. Furthermore, the review highlights promising research on optimizing treatment parameters and antibiotic combination strategies to maximize therapeutic outcomes. Despite its potential, aPDT faces obstacles to treatment standardization, variability in bacterial responses, and clinical implementation hurdles. These challenges require standardized protocols, further in vivo studies, and regulatory advancements to integrate aPDT into mainstream antimicrobial therapy. Conclusion: The synergy between aPDT and antibiotics represents a promising frontier in infection control, offering a safer, more effective, and resistance-mitigating strategy for bacterial infections. Future research should focus on refining treatment parameters, assessing long-term clinical impacts, and facilitating the widespread adoption of aPDT as a complementary antimicrobial approach.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsInfection ControlPhotochemotherapyAnimalsBacteriaDrug SynergismHumansPhotosensitizing AgentsReactive Oxygen SpeciesAnti-Bacterial AgentsPhotosensitizing AgentsReactive Oxygen Speciesantimicrobial strategiesmultidrug-resistancephotodynamic therapyreactive oxygen speciessynergistic effect

Identifiers

PMID40980827
PMCPMC12519489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.